stockrowPhio Pharmaceuticals Corp. (PHIO) vs Palatin Technologies, Inc. (PTN)
- Phio Pharmaceuticals Corp. PHIO 0.79 −1.25%
- Palatin Technologies, Inc. PTN 6.44 +12.78%
Phio Pharmaceuticals Corp. and Palatin Technologies, Inc. are both Biotechnology companies. Phio Pharmaceuticals Corp. and Palatin Technologies, Inc. are of similar size ($10.2M and $9.3M). Phio Pharmaceuticals Corp. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against 79.0%. Phio Pharmaceuticals Corp. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Phio Pharmaceuticals Corp. leads on 8 and Palatin Technologies, Inc. on 8.
Valuation
Profitability
| Metric | PHIO | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (65.74%) | 0.00% |
| Net margin | 0.00% | (63.54%) | 0.00% |
| Free cash flow margin | 0.00% | (103.07%) | 0.00% |
| Return on equity | (113.71%) | (877.60%) | (50.12%) |
| Return on assets | (100.78%) | (142.11%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack